News Numinus Wellness launches psychedelic-assisted therapy program for mental distress due to chronic illness The program includes four key initiatives that showcase Numinus' psychedelic research efforts Natalia Buendia CalvilloOctober 3, 2023
News Numinus Wellness reports 12.6% sequential revenue growth to $6M The growth is attributed to a high number of clients at its psychedelic-assisted therapy clinics Natalia Buendia CalvilloJuly 17, 2023
Psychedelics Optimi Health to supply MDMA for new psychedelic therapy program at Numinus clinics The experiential training will only be available through Numinus and will utilize the protocol of MAPS Rowan DunneJune 15, 2023
News Numinus Wellness YoY revenue increased five times to $5.4M Numinus clinic network generated $4.7 million in revenue during Q2 2023, showing a significant increase of 596.9 per cent from the same period last... Natalia Buendia CalvilloApril 13, 2023
News Numinus Wellness launches new psychedelics clinic licensing model for independent practitioners The company also partnered with Healing CREI to offer full operational clinics to their licensees Natalia Buendia CalvilloApril 11, 2023
News Numinus expands psychedelics research operations in Arizona This will be the company's fifth research clinic in the United States Natalia Buendia CalvilloFebruary 17, 2023
Psychedelics DOSED 2 set to premiere at Vogue Theatre in Vancouver Award-winning documentary sequel to be followed by Q&A with renowned psychedelic community figures Rowan DunneJuly 29, 2022
Business Numinus approved to study ayahuasca and San Pedro in Canada Used in sacred traditions for centuries, the firm says research will bring their medicinal benefits to a larger audience Natalia Buendia CalvilloMarch 9, 2022
Business Numinus develops in-house tests to detect compounds in psychedelic mushrooms The methods will be available as part of third-party client services Nick LabaNovember 29, 2021
The weed wire Numinus Wellness kicks off inaugural psilocybin mushroom crop Psychedelic mushrooms will be grown for research purposes Michelle GamageSeptember 25, 2020